Difficulty: Medium
Average Score: 80%
Practice
The following statements concerning drugs in heart failure are correct:
Correct answer
B
Rationale
The correct statement in this question is B) Candesartan (an angiotensin-II receptor antagonist) is generally better tolerated than captopril (an ACE inhibitor).
Explanation:
Candesartan, an angiotensin-II receptor antagonist, is indeed generally better tolerated than captopril, an ACE inhibitor, in patients with heart failure. This is because angiotensin-II receptor antagonists have a lower incidence of the bothersome side effect of cough that is commonly associated with ACE inhibitors. Additionally, angiotensin-II receptor antagonists are less likely to cause angioedema compared to ACE inhibitors, making them a preferred choice in some heart failure patients.
Why the other options are incorrect:
A) The combination of furosemide (a loop diuretic) and ramipril (an ACE inhibitor) should be avoided: This statement is incorrect. The combination of a loop diuretic and an ACE inhibitor is a common and effective treatment strategy in heart failure management.
C) Beta blockers are contraindicated in heart failure: This statement is incorrect. Beta blockers are actually a cornerstone in the management of heart failure and have been shown to improve outcomes and reduce mortality in patients with heart failure.
D) The combination of loop diuretic, ACE inhibitor, and spironolactone must always be avoided because of the risk of hyperkalemia: This statement is incorrect. While it is important to monitor potassium levels when using a combination of medications that can increase potassium levels, such as an ACE inhibitor, a loop diuretic, and spironolactone, this combination is commonly used in heart failure patients to optimize treatment outcomes.
Educational context:
Understanding the differences in the tolerability and efficacy of various medications used in heart failure is crucial for healthcare professionals managing patients with this condition. It is important to be aware of the side effect profiles of different drug classes to tailor treatment to individual patient needs and optimize outcomes. Knowledge of the mechanisms of action and potential adverse effects of cardiovascular drugs is essential for providing safe and effective care to patients with heart failure.
Explanation:
Candesartan, an angiotensin-II receptor antagonist, is indeed generally better tolerated than captopril, an ACE inhibitor, in patients with heart failure. This is because angiotensin-II receptor antagonists have a lower incidence of the bothersome side effect of cough that is commonly associated with ACE inhibitors. Additionally, angiotensin-II receptor antagonists are less likely to cause angioedema compared to ACE inhibitors, making them a preferred choice in some heart failure patients.
Why the other options are incorrect:
A) The combination of furosemide (a loop diuretic) and ramipril (an ACE inhibitor) should be avoided: This statement is incorrect. The combination of a loop diuretic and an ACE inhibitor is a common and effective treatment strategy in heart failure management.
C) Beta blockers are contraindicated in heart failure: This statement is incorrect. Beta blockers are actually a cornerstone in the management of heart failure and have been shown to improve outcomes and reduce mortality in patients with heart failure.
D) The combination of loop diuretic, ACE inhibitor, and spironolactone must always be avoided because of the risk of hyperkalemia: This statement is incorrect. While it is important to monitor potassium levels when using a combination of medications that can increase potassium levels, such as an ACE inhibitor, a loop diuretic, and spironolactone, this combination is commonly used in heart failure patients to optimize treatment outcomes.
Educational context:
Understanding the differences in the tolerability and efficacy of various medications used in heart failure is crucial for healthcare professionals managing patients with this condition. It is important to be aware of the side effect profiles of different drug classes to tailor treatment to individual patient needs and optimize outcomes. Knowledge of the mechanisms of action and potential adverse effects of cardiovascular drugs is essential for providing safe and effective care to patients with heart failure.